ASSOCIATION OF GLUTATHIONE-S-TRANSFERASE
(GSTM1 and GSTT1) AND FTO GENE POLYMORPHISMS
WITH TYPE 2 DIABETES MELLITUS CASES
IN NORTHERN INDIA
Raza ST, Abbas S, Ahmad A, Ahmed F, Zaidi ZH, Mahdi F
*Corresponding Author: Syed Tasleem Raza, Ph.D., Molecular Biology Laboratory, Department of Biochemistry,
Era’s Lucknow Medical College and Hospital, Hardoi Road, Lucknow, Uttar Pradesh, India 226025. Tel.: +91-522-
240-8122; 240-8123. Fax: +91-522-240-7824. E-mail: tasleem24@gmail.com
page: 47
|
|
REFERENCES
1. Wild S, Roglic G, Green A, Sicree R, King H.
Global prevalence of diabetes: Estimates for
the year 2000 and projections for 2030. Diabetes
Care. 2004; 27(5): 1047-1053.
2. Gupta V, Khadgawat R, Saraswathy KN, Sachdeva
MP, Kalla AK. Emergence of TCF7L2
as a most promising gene in predisposition of
diabetes type II. Int J Hum Genet. 2008; 8(1-2):
199-215.
3. Das SK. Genetic epidemiology of adult onset
T2Din Asian Indian population: Past, present
and future. Int J Hum Genet. 2006; 6(1): 1-13.
4. Opara EC. Oxidative stress, micronutrients,
diabetes mellitus and its complications. J R Soc
Promot Health. 2002; 122(1): 28-34.
5. Friedly LE, Philipson LH. Oxidative reactive
species in cell injury: Mechanism in diabetes
mellitus and therapeutic approaches. Ann N Y
Acad Sci 2005; 1066: 136-151.
6. Bekris LM, Shephard C, Peterson J, Hoehna B,
Van Yserloo E, Rutledge F, et al. Glutathionestransferase
M1 and T1 polymorphisms and associations
with type 1 diabetes age-at-onset.
Autoimmunity. 2005; 38(8): 567-575.
7. Amer MA, Ghattas MH, Abo-ElMatty DM,
Abou-El-Ela SH. Influence of glutathione Stransferase
polymorphisms on type-2 diabetes
mellitus risk. Genet Mol Res. 2011; 10(4):
3722-3730.
8. Ramprasath T, Senthil Murugan P, Prabakaran
AD, Gomathi P, Rathinavel A, Selvam GS. Potential
risk modifications of GSTT1, GSTM1
and GSTP1 (glutathione-S transferase) variants
and their association to CAD in patients with
type-2 diabetes. Biochem Biophys Res Commun.
2011; 407(1): 49-53.
9. Hori M, Oniki K, Ueda, Goto S, Mihara S,
Marubayashi T, et al. Combined glutathione Stransferase
T1 and M1 positive genotypes afford
protection against type 2 diabetes in Japanese.
Pharmacogenomics. 2007; 8(10): 1307-1314.
10. Datta SK, Kumar V, Pathak R, Tripathi AK,
Ahmed RS, Kaira OP, et al. Association of glutathione
S-transferase M1 and T1 gene polymorphism
with oxidative stress in diabetic and
nondiabetic chronic kidney disease. Ren Fail.
2010; 32(10): 1189-1195.
11. Yang Y, Kao MT, Chang CC, Chen CM, Tsai JJ,
Chang JG. Glutathione S-transferase T1 deletion
is a risk factor for developing end-stage
renal disease in diabetic patients. Int J Mol
Med. 2004; 14(5): 855-859.
12. Hinney A. Genome wide association (GWA)
study for early onset extreme obesity supports
the role of fat mass and obesity associated gene
(FTO) variants. PloS ONE. 2007; 2(12): e1361.
13. Scuteri A, Sanna S, Chen WM, Uda M, Albai
G, Strait J, et al. Genome-wide association scan
shows genetic variants in the FTO gene are associated
with obesity-related traits. Plos Genet.
2007; 3(7): 1200-1210.
14. Fredriksson R, Hagglund M, Olszewski PK,
Stephansson O, Jacobsson JA, Olszewska AM, et
al. The obesity gene, FTO, is of ancient origin,
up-regulated during food deprivation and expressed
in neurons of feeding-related nuclei of the
brain. Endocrinology. 2008; 149(5): 2062-2071.
15. Stratigopoulos G, Padilla SL, Leduc CA, Watson
E, Hattersley AT, McCarthy MI, et al. Regulation
of Fto/ Ftm gene expression in mice and
humans. Am J Physiol Regul Integr Comp
Physiol. 2008; 294(4):R1185-R1196.
16. Wahlen K, Sjolin E, Hoffstedt J. The common
rs9939609 gene variant of the fat mass- and obesity-
associated gene FTO is related to fat cell lipolysis.
J Lipid Res. 2008; 49(3): 607-661.
17. Li H, Kilpeläinen TO, Liu C. Association of genetic
variation in FTO with risk of obesity and
type 2 diabetes with data from 96,551 East and
South Asians. Diabetologia. 2012; 55(4): 981-995.
18. Hertel JK, Johansson S, Sonestedt E, Jonsson
A, Lie RT, Platou CG, et al. FTO, type 2 diabetes,
and weight gain throughout adult life: A
meta-analysis of 41,504 subjects from the
Scandinavian HUNT, MDC, and MPP studies.
Diabetes. 2011; 60(5): 1637-1644.
19. Friedewald WT, Levy RI, Fredrickson DS. Estimation
of the concentration of low density lipoprotein
cholesterol in plasma, without use of
the preparative ultracentrifuge. Clin Chem.
1972; 18(6): 499-450.
20. Sambrook J, Frisch EF, Maniatis T, Eds. Molecular
Cloning: A Laboratory Manual, 2nd ed.
New York, NY: Cold Spring Harbor Press.
1989: 9.14-9.19.
21. Arand M, Mühlbauer R, Hengstler J, Jäger E,
Fuchs J, Winkler L, et al. A multiplex polymerase
chain reaction protocol for the simultaneous
analysis of the glutathione S-transferase
GSTM1 and GSTT1 polymorphisms. Anal
Biochem. 1996; 236(1): 184-186.
22. Hao K, Niu T, Sangokoya C, Li J, Xu X. SNP
kit: An efficient approach to systematic evaluation
of candidate single nucleotide polymorphisms
in public databases. BioTechniques.
2002; 33(4): 822-848.
23. Stephens JW, Khanolkar MP, Bain SC. The biological
relevance and measurement of plasma
markers of oxidative stress in diabetes and cardiovascular
disease. Atherosclerosis. 2009;
202(2): 321-329.
24. Wang L, Zhang Q, Li Q. Genetic polymorphisms
of GSTT1, GSTM1, and NQO1 genes
and diabetes mellitus risk in Chinese population.
Biochem Biophys Res Commun. 2006;
341: 310-313.
25. London SJ, Yuan JM, Chung FL, Gao YT. Isothiocyanates,
glutathione S-transferase M1 and
T1 polymorphisms, and lung-cancer risk: A prospective study of men in Shanghai, China.
Lancet. 2000; 356(9231): 724-729.
26. Yuille M, Condie A, Hudson C, Kote-Jarai Z,
Stone E, Eeles R, et al. Relationship between
glutathione S-transferase M1, T1, and P1 polymorphisms
and chronic lymphocytic leukemia.
Blood. 2002; 99(11): 4216-4218.
27. Chen K, Jiang QT, He HQ. Relationship between
metabolic enzyme polymorphism and
colorectal cancer. World J. Gastroenterol. 2005;
11(3): 331-335.
28. Nowier SR, Kashmiry NK, Rasool HA, Morad
H, Ismail S. Association of T2DMellitus and
glutathione S transferase (GSTM1 and GSTT1)
genetic polymorphism. Res J Med Med Sci.
2009; 4(2): 181-188.
29. Hossaini AM, Zamrroni IM, Kashem RA, Khan
ZF. Polymorphism of glutathione S-transferases
as genetic risk factors for the development of
complications in T2D mellitus. J Crit Care.
2008; 23(3):444-448.
30. Bid HK, Konwar R, Saxena M, Chaudhari P,
Agrawal CG, Banerjee M. Association of glutathione
S-transferase (GSTM1, T1 and P1) gene
polymorphisms with type 2 diabetes mellitus in
north Indian population. J Postgrad Med. 2010;
56(3): 176-181.
31. Frayling TM, Timpson NJ, Weedon MN, Zeggini
E, Freathy RM, Lindgren CM, et al. A
common variant in the FTO gene is associated
with body mass index and predisposes to childhood
and adult obesity. Science. 2007;
316(5826): 889-894.
32. Sanghera DK, Ortega L, Han S, Singh J, Ralhan
SK, Wander GS, et al. Impact of nine common
T2D risk polymorphisms in Asian Indian
Sikhs: PPARG2 (Pro12 Ala), IGF2BP2, TCF7L2
and FTO variants confer a significant
risk. BMC Med Genet. 2008; 9: 59. doi:
10.1186/ 1471-2350-9-59.
33. Yajnik CS, Janipalli CS, Bhaskar S, Kulkarni
SR, Freathy RM, Prakash S, et al. FTO gene
variants are strongly associated with type 2 diabetes
in South Asian Indians. Diabetologia.
2009; 52(2): 247-252.
34. Pirie FJ, Motala AA, Pegoraro J, Paruk IM,
Govender T, Rom L. Variants in PPARG,
KCNJ11, TCF7L2, FTO, and HHEX genes in
South African subjects of Zulu descent with
type 2 diabetes. Afr J Diabetes Med. 2010;
18(1): 12-16.
35. Doney AS, Dannfald J, Kimber CH, Donnelly
LA, Pearson E, Morris AD, et al. The FTO gene
is associated with an atherogenic lipid profile
and myocardial infarction in patients with type
2 diabetes: A Genetics of Diabetes Audit and
Research Study in Tayside Scotland (Go-
DARTS) study. Circ Cardiovasc Genet. 2009;
2(3): 255-259.
36. Ortega-Azorín C, Sorlí JV, Asensio EM, Coltell
O, Martínez-González MÁ, Salas-Salvadó J, et
al. Associations of the FTO rs9939609 and the
MC4R rs17782313 polymorphisms with type 2
diabetes are modulated by diet, being higher
when adherence to the Mediterranean diet pattern
is low. Cardiovasc Diabetol. 2012; 11: 137.
|
|
|
|
 |
Number 27
VOL. 27 (2), 2024 |
Number 27
VOL. 27 (1), 2024 |
Number 26
Number 26 VOL. 26(2), 2023 All in one |
Number 26
VOL. 26(2), 2023 |
Number 26
VOL. 26, 2023 Supplement |
Number 26
VOL. 26(1), 2023 |
Number 25
VOL. 25(2), 2022 |
Number 25
VOL. 25 (1), 2022 |
Number 24
VOL. 24(2), 2021 |
Number 24
VOL. 24(1), 2021 |
Number 23
VOL. 23(2), 2020 |
Number 22
VOL. 22(2), 2019 |
Number 22
VOL. 22(1), 2019 |
Number 22
VOL. 22, 2019 Supplement |
Number 21
VOL. 21(2), 2018 |
Number 21
VOL. 21 (1), 2018 |
Number 21
VOL. 21, 2018 Supplement |
Number 20
VOL. 20 (2), 2017 |
Number 20
VOL. 20 (1), 2017 |
Number 19
VOL. 19 (2), 2016 |
Number 19
VOL. 19 (1), 2016 |
Number 18
VOL. 18 (2), 2015 |
Number 18
VOL. 18 (1), 2015 |
Number 17
VOL. 17 (2), 2014 |
Number 17
VOL. 17 (1), 2014 |
Number 16
VOL. 16 (2), 2013 |
Number 16
VOL. 16 (1), 2013 |
Number 15
VOL. 15 (2), 2012 |
Number 15
VOL. 15, 2012 Supplement |
Number 15
Vol. 15 (1), 2012 |
Number 14
14 - Vol. 14 (2), 2011 |
Number 14
The 9th Balkan Congress of Medical Genetics |
Number 14
14 - Vol. 14 (1), 2011 |
Number 13
Vol. 13 (2), 2010 |
Number 13
Vol.13 (1), 2010 |
Number 12
Vol.12 (2), 2009 |
Number 12
Vol.12 (1), 2009 |
Number 11
Vol.11 (2),2008 |
Number 11
Vol.11 (1),2008 |
Number 10
Vol.10 (2), 2007 |
Number 10
10 (1),2007 |
Number 9
1&2, 2006 |
Number 9
3&4, 2006 |
Number 8
1&2, 2005 |
Number 8
3&4, 2004 |
Number 7
1&2, 2004 |
Number 6
3&4, 2003 |
Number 6
1&2, 2003 |
Number 5
3&4, 2002 |
Number 5
1&2, 2002 |
Number 4
Vol.3 (4), 2000 |
Number 4
Vol.2 (4), 1999 |
Number 4
Vol.1 (4), 1998 |
Number 4
3&4, 2001 |
Number 4
1&2, 2001 |
Number 3
Vol.3 (3), 2000 |
Number 3
Vol.2 (3), 1999 |
Number 3
Vol.1 (3), 1998 |
Number 2
Vol.3(2), 2000 |
Number 2
Vol.1 (2), 1998 |
Number 2
Vol.2 (2), 1999 |
Number 1
Vol.3 (1), 2000 |
Number 1
Vol.2 (1), 1999 |
Number 1
Vol.1 (1), 1998 |
|
|
